Alpha Teknova Inc
TKNO4.328USD
+0.088+2.08%
交易中 （美东）报价延迟15分钟
231.28M总市值
亏损市盈率 TTM
关于 Alpha Teknova Inc 公司
Alpha Teknova, Inc. 是治疗、疫苗和分子诊断研究、发现、开发和商业化关键试剂的生产商。该公司提供两条主要业务线，包括实验室必需品和临床解决方案。该公司还提供三种主要产品类型：用于细胞生长和克隆的预灌装培养基板；用于细胞扩增的液体细胞培养基和补充剂；以及用于样品处理、再悬浮和纯化的分子生物学试剂。该公司在其两个产品类别中都提供液体细胞培养基和补充剂以及分子生物学试剂；预灌装培养基板仅在其实验室必需品类别中提供。其客户包括制药和生物技术公司、合同开发和制造组织、体外诊断特许经营商以及开发疫苗和治疗并进行基础研究的学术和政府研究机构。
公司简介
公司代码TKNO
公司名称Alpha Teknova Inc
上市日期Jun 25, 2021
CEOMr. Stephen Gunstream
员工数量173
证券类型Ordinary Share
年结日Jun 25
公司地址2451 Bert Drive
城市HOLLISTER
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编95023
电话18316371100
网址https://www.teknova.com/
公司代码TKNO
上市日期Jun 25, 2021
CEOMr. Stephen Gunstream
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
Mr. Alexander C. Herzick
Mr. Alexander C. Herzick
Director
Director
--
--
Ms. Brett M. Robertson
Ms. Brett M. Robertson
Independent Director
Independent Director
--
--
Mr. J. Matthew Mackowski
Mr. J. Matthew Mackowski
Director
Director
--
--
Mr. Matthew C. Lowell
Mr. Matthew C. Lowell
Chief Financial Officer
Chief Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Lab Essentials
8.12M
82.87%
Clinical Solutions
1.16M
11.86%
Other
516.00K
5.27%
地区USD
名称
营收
占比
United States
9.27M
94.66%
International
523.00K
5.34%
业务
地区
业务USD
名称
营收
占比
Lab Essentials
8.12M
82.87%
Clinical Solutions
1.16M
11.86%
Other
516.00K
5.27%
股东统计
更新时间: 7月9日 周三
更新时间: 7月9日 周三
持股股东
股东类型
持股股东
持股股东
占比
Telegraph Hill Partners
70.58%
Davis (Ted)
3.53%
Davis (Irene)
3.16%
UBS Financial Services, Inc.
2.17%
Balyasny Asset Management LP
1.57%
Other
19.00%
持股股东
持股股东
占比
Telegraph Hill Partners
70.58%
Davis (Ted)
3.53%
Davis (Irene)
3.16%
UBS Financial Services, Inc.
2.17%
Balyasny Asset Management LP
1.57%
Other
19.00%
股东类型
持股股东
占比
Private Equity
70.58%
Individual Investor
10.77%
Investment Advisor
5.23%
Hedge Fund
3.12%
Investment Advisor/Hedge Fund
2.40%
Research Firm
0.82%
Pension Fund
0.15%
Other
6.93%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
131
49.74M
93.07%
-991.18K
2025Q1
159
49.02M
94.72%
+9.59M
2024Q4
142
49.19M
92.33%
+11.09M
2024Q3
142
47.90M
89.93%
+8.81M
2024Q2
140
36.69M
87.73%
-3.53M
2024Q1
145
36.60M
90.14%
-2.50M
2023Q4
149
35.47M
91.35%
-3.28M
2023Q3
155
35.09M
90.51%
+4.53M
2023Q2
176
26.14M
92.65%
-5.67M
2023Q1
173
27.23M
97.10%
+13.65M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Telegraph Hill Partners
37.72M
70.58%
--
--
Apr 22, 2025
Davis (Ted)
1.89M
3.53%
--
--
Apr 22, 2025
Davis (Irene)
1.69M
3.16%
--
--
Apr 22, 2025
UBS Financial Services, Inc.
1.16M
2.17%
+46.45K
+4.17%
Mar 31, 2025
Balyasny Asset Management LP
836.96K
1.57%
-164.71K
-16.44%
Mar 31, 2025
Mackowski J Matthew
820.81K
1.54%
--
--
Apr 22, 2025
Lowell (Matthew)
820.81K
1.54%
+701.77K
+589.51%
Apr 22, 2025
The Vanguard Group, Inc.
573.45K
1.07%
+33.21K
+6.15%
Mar 31, 2025
CenterBook Partners LP
304.55K
0.57%
+304.55K
--
Mar 31, 2025
Wexford Capital LP
275.00K
0.51%
+275.00K
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ProShares Nanotechnology ETF
0.6%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Micro-Cap ETF
0.01%
iShares Biotechnology ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares UltraPro Russell2000
0%
查看更多
ProShares Nanotechnology ETF
占比0.6%
Invesco Nasdaq Biotechnology ETF
占比0.03%
ProShares Ultra Nasdaq Biotechnology
占比0.03%
iShares Micro-Cap ETF
占比0.01%
iShares Biotechnology ETF
占比0.01%
Dimensional US Core Equity 1 ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
Invesco Dorsey Wright SmallCap Momentum ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
ProShares UltraPro Russell2000
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
